EDTA

A Doctor-Trusted IV & Suppository Chelator for Removing Toxic Metals

CaEDTA (Calcium Disodium Ethylenediaminetetraacetic Acid) has been used for decades as a trusted medical chelator to remove heavy metals from the body safely. It is especially effective against lead and cadmium, two of the most hazardous metals associated with cardiovascular, neurological, and kidney damage. It is administered professionally either as a slow drip or quick "push." Or it can be self- administered as a suppository

123

I have a prescription

I need a prescription ($49 Consultation)

Buy EDTA without a prescription

Get to know

EDTA

Gradual Heavy Metal Chelation

CaEDTA binds to toxic metals like lead, cadmium, and to a lesser degree, mercury. It also binds to heavy metals such as iron. The primary route of excretion for EDTA is believed to be the digestive track. By lowering metal buildup, it helps protect vital organs and restore energy, particularly circulation, and it can be used for anti-aging and overall wellness.

Doctor-Supervised for Maximum Benefit

CaEDTA is considered to have a broad, sometimes subtle, affinity for both toxic and beneficial metals. It is usually used more often, and longer, than other chelators. Because it can affect beneficial minerals, doctor-supervision is always recommended.

IV Treatment for Maximum Effectiveness

pharmaRESOLVE prescribers do not prescribe oral CaEDTA because it is used for longer periods of time than other chelators. Long-term oral chelation could interfere with nutrient update, particularly beneficial minerals.

More about

EDTA

What is the most important information I should know about CaEDTA?

CaEDTA may cause serious side effects. Tell your healthcare provider if you have any of these symptoms:

Arrhythmia Exacerbation:

Arrhythmia refers to an abnormal heart rhythm, where the heart may beat too fast, too slow, or irregularly.
Arrhythmia exacerbation indicates a worsening or aggravation of an existing arrhythmia potentially leading to more severe symptoms or complications.

Angioedema:

Angioedema is a medical condition in which localized swelling beneath the skin’s surface occurs, typically affecting deeper layers of the skin and mucous membranes

Proteinuria & amp; Renal Toxicity:

One of the most common visible signs of proteinuria is the presence of foamy or frothy urine. This occurs because proteins, particularly albumin, create bubbles as they mix with urine.

Bodily Minerals Depletion:

CaEDTA’s affinity for iron can cause anemia and other iron-deficiency related issues.
CaEDTA can also cause zinc, copper, potassium, and phosphorus deficiencies.
Essential minerals should be monitored, especially with long-term use of CaEDTA.

Allergies:

Allergic reactions are rare but possible. Any unusual or severe reactions, such as rash, swelling, trouble breathing, or skin irritation, should be reported to your healthcare provider.

Do not use CaEDTA if:

Anuria (absence of urine production): If you have a known allergy or sensitivity to DMSA or any of Its components. you should not use thts medication, Allergic reactions can be severe and life-threatening.
Active Renal Disease: DMSA IS primarily excreted through the kidneys. If you have severe kidney impairment or renal failure, your healthcare provider may need to adjust the dosage or consider alternative treatments, as DMSA can accumulate in the body.
Allergy or Sensitivity: If you have. or are at risk for neutropenia. (Iow white blood cell count).
Neutropenia: If you have concerns about blood health, be aware that other side effects may include a temporary drop in hemoglobin levels and low white blood cells (neutropenia).
Severe Liver Impairment: Extra precautions may be necessary for patients with liver impairment.

What are the possible side effects of CaEDTA?

CaEDTA may cause serious side effects, including:

Body as a Whole: Some patients may experience discomfort at the injection site, along with flu-like symptoms such as fever, chills, general discomfort (malaise), fatigue, muscle pain (myalgia), and joint pain (arthralgia).
Cardiovascular: The therapy can lead to low blood pressure (hypotension) and irregular heart rhythms, which may require medical attention.
Renal: In severe cases, the drug may cause damage to the kidneys, which, if continued, could cause fatal kidney failure (nephrosis).
Urinary: The therapy may cause sugar (glycosuria) and protein (proteinuria) to appear in the urine, along with microscopic blood traces (hematuria) and the presence of large epithelial cells in urine sediment, indicating possible kidney or urinary tract irritation.
Nervous System: Some patients may experience neurological effects such as tremors, headaches, numbness, and tingling sensations, which can be signs of nerve involvement.
Gastrointestinal: The drug can lead to digestive issues, including cracked lips (cheilosis), nausea, vomiting, loss of appetite (anorexia), and excessive thirst, which may indicate dehydration or metabolic disturbances.
Hepatic: Mild, temporary increases in liver enzymes (SGOT and SGPT) are common but usually resolve within 48 hours after stopping treatment, indicating a transient liver reaction.
Immunogenic: Some individuals may experience histamine-like allergic reactions, including sneezing, nasal congestion, watery eyes (lacrimation), and skin rashes.
Hematopoietic: The drug may cause temporary suppression of bone marrow activity, leading to a decrease in blood cell production, resulting in anemia.
Metabolic: It may disrupt essential mineral balances, usually leading to deficiencies in zinc, copper, iron, potassium, and phosphorous, or other minerals. Beneficial mineral level monitoring is necessary when removing toxic heavy metals.

Most common side effect of CaEDTA is diminishment of beneficial minerals such as iron, leadingto momentary anemia, and low zinc, copper, or phosphorous levels the absence of which cancause health issues which normally resolve as the beneficial minerals are replaced.